2020年2月18日,Javier Cortes团队在国际顶级癌症期刊《CA: A Cancer Journal for Clinicians》(影响因子高达223.679)在线发表“Enhancing global access to cancer medicines”的综述文章,综述阐述了各类限制人们获得癌症药.....
[1]Jonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, et al. Durvalumab,with or without tremelimumab,plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung